Some of the New Yorkers who ran toward the World Trade Center on Sept. 11 are now facing a grim, microscopic aftermath. A Stony Brook–led research team reports that World Trade Center responders diagnosed with post-traumatic stress disorder show molecular signs of accelerated biological aging, along with a higher risk of chronic disease, even decades after the attacks.
The study zeroes in on tiny shifts in proteins and metabolites that line up with immune, metabolic and oxidative-stress pathways, offering a biochemical explanation for why some survivors develop age-related illnesses earlier than doctors might expect.
What the researchers analyzed
Scientists working with the Stony Brook World Trade Center Health Program examined plasma samples using high-throughput proteomics and targeted metabolomics. According to a Stony Brook University news release, the team analyzed blood from 393 responders collected nearly 18 years after the attacks. That group included 232 people with PTSD and 161 trauma-exposed responders who did not have PTSD, and the researchers identified dozens of molecular differences between them.
The work, led by Benjamin J. Luft and Pei-Fen Kuan, is described as one of the most comprehensive combined proteomic and metabolomic profiles of PTSD assembled so far.
Molecular signals point to multisystem aging
In a paper published in Nature Communications, the researchers report measuring roughly 9,400 proteins using SomaScan and profiling 145 targeted metabolites. They found 114 proteins and seven metabolites that differed significantly between the PTSD group and the control group.
The altered molecules included markers tied to brain function, energy metabolism and oxidative stress. Pathway analyses pointed to processes involving neuronal plasticity, immune activation and extracellular-matrix remodeling.
Using proteomic organ-aging estimates, the team saw signs of accelerated aging across multiple organs, most notably in the pancreas and lungs, as well as at the whole-body level.
Limits and what the study does not prove
The authors are clear about what this research cannot say. Because the analysis was cross-sectional, it captures a single moment in time rather than tracking changes as they unfold. That means the work shows associations, not proof that PTSD directly caused the molecular shifts.
As reported by FOX 5 Atlanta, lead author Benjamin Luft explained, “Because all measurements were taken at one point in time, the research can only show an association, not that PTSD directly caused the changes.” The team also notes that the unusual mix of toxins, dust and trauma faced by World Trade Center responders may limit how broadly these findings apply to other PTSD populations.
Why the findings matter for care and policy
Researchers say these molecular signatures could eventually help flag which responders face the highest risk of early-onset disease and could guide closer monitoring or targeted treatments. That is still a long-term goal. They stress that longer, follow-up studies are needed before blood markers can be used in routine care.
Stony Brook reports that investigators are already running longitudinal studies with multiple time points to see whether particular proteins or metabolites show up before clinical decline, according to the university release.
The results also add scientific weight to calls for permanent support for those who responded on 9/11. Congress moved earlier this year to lock in coverage for the World Trade Center Health Program, as reported by finally get health care for life.
For responders and the clinicians who care for them, the study reinforces a “whole-body” view of PTSD. It highlights the importance of tightly coordinated mental and physical health follow-up while researchers continue to test whether blood-based markers can eventually help shape prevention and treatment strategies.
